Combining free and total prostate specific antigen assays from different manufacturers: The pitfalls

European Urology

Volumn 42, Issue 6, 2002, Pages 577-582

  Oberpenning, Frank ^a   Weining, Christoph ^a   Brandt, Burkhard ^a   De Angelis, Gabriela ^a   Heinecke, Achim ^a   Hamm, Michael ^b   Stieber, Petra ^c   Hertle, Lothar ^a   Schmidf, Hans Peter ^d   Semjonow, Axel ^a   Djavan, B ^e  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

^e NONE

Author keywords

Benign prostatic hyperplasia; Comparative study; Human; Immunoassay; Prostate specific antigen; Prostatic neoplasms; Protein isoforms; Reagent kits; Tumor markers

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; ASSAY; BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY; AGED; ANALYTICAL EQUIPMENT; BLOOD; MIDDLE AGED; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REAGENT KITS, DIAGNOSTIC;

EID: 0036904602     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00449-9     Document Type: Article

References (23)

1. Catalona WJ, Richie JP, Ahmann FR. Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol 1994;151:1283-90.
2. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
3. Christensson A, Björk T, Nilsson O, Dahlen U, Matikainen MT, Cockett AT, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150:100-5.
4. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial. JAMA 1998;279: 1542-7.
5. Gann PH, Ma J, Catalona WJ, Stampfer MJ. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: A prospective evaluation. J Urol 2002;167:2427-34.
6. Blase AB, Sokoloff RL, Smith KM. Five PSA methods compared by assaying samples with defined PSA ratios. Clin Chem 1997;43: 843-5.
7. Semjonow A, Oberpenning F. Weining C, Schön M, Brandt B, De Angelis G, et al. Do modifications of non-equimolar assays for total prostate-specific antigen improve detection of prostate cancer? Clin Chem 2001;47:1472-5.
8. Semjonow A, Oberpenning F, Brandt B, Zechel C, Brandau W, Hertle L. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen. Urology 1996;48(Suppl 6A):10-5.
9. Semjonow A, Brandt B, Oberpenning F, Roth S, Hertle L. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values. Prostate 1996;7:3-16.
10. Graves HC, Wehner N, Stamey TA. Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an international antigen standard. J Urol 1990;144:1516-22.
11. Semjonow A, Weining C, Oberpenning F, Heinecke A, Terpe A, Schmid HP. et al. Application of assay-specific cut-off values: Results of the assay comparison study for PSA. Eur Urol 1999;35(Suppl 2):18.
12. Reiter W, Stieber P, Schmeller N, Nagel D, Hofmann K. Fateh-Moghadam A. Total and free PSA: A methodical and clinical evaluation of five assays. Anticancer Res 1997;17:4759-65.
13. Junker R, Brandt B, Zechel C, Assmann G. Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clin Chem 1997;43:1588-94.
14. Roehrborn CG, Gregory A, McConnell JD, Sagalowsky AI, Wians Jr FH. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology. Urology 1996;48:23-32.
15. Patel D, White PA, Milford Ward A. A comparison of six commercial assays for total and free prostate specific antigen (PSA): The predictive value of the ratio of free-to-total PSA. Br J Urol 2000;85:686-9.
16. Woodrum DL, Brawer MK, Partin AW. Catalona WJ, Southwick PC. Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol 1998;159:5-12.
17. Jung K, Lein M, Brux B, Sinha P, Schnorr D, Loening SA. Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions. Clin Chem Lab Med 2000;38:1271-5.
18. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983:148:839-43.
19. Woodrum D, French C, Shamel LB. Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology 1996;48:33-9.
20. Piironen T, Pettersson K, Suonpaa M, Stenman UH, Oesterling JE, Lövgren T, Lilja H. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. Urology 1996;48:81-7.
21. Jung K, Stephan C, Lein M,. Henke W, Schnorr D, Brux B, et al. Analytical performance and clinical validity of two free prostate-specific antigen assays compared. Clin Chem 1996;42:1026-33.
22. Chan DW, Sokoll LJ, Jones KA, Kelley CA, Subong ENP, Partin AW. Clinical evaluation of two free PSA assays in combination with different total PSA assays. J Urol 1997;157(Suppl):112.
23. Nixon RG, Meyer GE, Blase AB, Gold MH, Brawer MK. Comparison of three investigational assays for the free form of prostate specific antigen. J Urol 1998;160:420-5.